Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NetraMark Holdings Inc C.AIAI

Alternate Symbol(s):  AINMF

Healthcare Medical Devices
NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several... see more

Recent & Breaking News (CSE:AIAI)

NETRAMARK ANNOUNCES CLOSING OF PRIVATE PLACEMENT

Canada NewsWire March 24, 2023

HEALTHCARE STRATEGY LEADER JOINS NETRAMARK ADVISORY BOARD

Canada NewsWire March 21, 2023

NETRAMARK UNCOVERS UNIQUE ALZHEIMER'S DISEASE SUBTYPES

Canada NewsWire March 15, 2023

PHARMACEUTICAL INDUSTRY VETERAN JOINS NETRAMARK ADVISORY BOARD

Canada NewsWire March 8, 2023

NETRAMARK RELEASES PAPER DEMONSTRATING AI CAPABILITIES TO DERIVE INSIGHTS USING CLINICAL SCALE DATA

Canada NewsWire February 27, 2023

CSE Bulletin: Name and Symbol Change - Nurosene Health Inc. (MEND)

Newsfile January 30, 2023

INTRODUCING NETRAMARK - A PHARMA AI COMPANY

PR Newswire January 30, 2023

NUROSENE ANNOUNCES ADVISORY ROLE WITH RARE-X

PR Newswire January 18, 2023

NUROSENE CHIEF SCIENCE OFFICER PRESENTS AT LEADING DRUG DEVELOPMENT FORUM

Canada NewsWire December 6, 2022

NUROSENE BUSINESS UPDATE

PR Newswire December 1, 2022

NUROSENE HEALTH INC. ANNOUNCES CLOSING OF PRIVATE PLACEMENT

Canada NewsWire October 31, 2022

NUROSENE HEALTH INC. ANNOUNCES CLOSING OF PRIVATE PLACEMENT

PR Newswire October 14, 2022

NUROSENE APPOINTS NEUROSURGEON DR. DOUGLAS JAMES COOK AS CHIEF MEDICAL OFFICER

Canada NewsWire August 24, 2022

Nurosene Appoints New Advisory Board Member Dhananja Jayalath

Canada NewsWire August 23, 2022

NUROSENE APPOINTS INDUSTRY VETERAN DR. LUCA PANI AS CHIEF INNOVATION AND REGULATORY OFFICER

Canada NewsWire July 22, 2022

NUROSENE ANNOUNCES APPOINTMENT OF NEW CFO

Canada NewsWire July 18, 2022

NUROSENE APPOINTS SEASONED EXECUTIVE JOSH SPIEGEL AS PRESIDENT OF NETRAMARK

Canada NewsWire July 14, 2022

NUROSENE ANNOUNCES AGREEMENT WITH DENOVO BIOPHARMA LLC TO OPTIMIZE TREATMENT-RESISTANT DEPRESSION TRIAL

Canada NewsWire July 6, 2022

NUROSENE ENTERS INTO AGREEMENT WITH TAYLORED BIOTHERAPEUTICS TO EVALUATE CLINICAL TRIAL RESULTS

Canada NewsWire June 22, 2022

NUROSENE HEALTH INC. ANNOUNCES CHANGE IN MANAGEMENT

Canada NewsWire June 10, 2022